Imperva (IMPV) Tops Q1 EPS by 12c; Guides FY15

Imperva (NYSE: IMPV) reported Q1 EPS of ($0.26), $0.12 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $44.8 million versus the consensus estimate of $40.5 million.

Imperva sees FY2015 EPS of ($0.77)-($0.63), versus the consensus of ($0.85). Imperva sees FY2015 revenue of $202-207 million, versus the consensus of $198.8 million.

For earnings history and earnings-related data on Imperva (IMPV) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c
• Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance